A look at the deconditioning cascade that starts when regular exercise stops — and how hard it is to fight your way back to ...

A mouse study finds that the KCNE3-KCNQ1 potassium channel axis couples mitochondrial energy metabolism to vessel growth and ...

A new letter to the editor challenges a transcriptomic study linking collagen-rich extracellular matrix to postoperative ...

Solventum Corporation SOLV recently received FDA 510(k) clearance for the combined use of its Restrata Synthetic Electrospun ...

As published in the Journal of Clinical Oncology (JCO) and presented at ESMO, COMPANION-002 met its primary endpoint of ORR and key secondary ...

CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...

Arcus Biosciences casdatifan combinations showed superior or competitive PFS and response rates versus historical benchmarks.

BioNTech enters a clinical trial collaboration with Gilead Sciences with the aim of improving outcomes in patients with PD-L1 low or negative ...

Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. Food and Drug Administration (FDA) ...

Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit's license territories, ...

PD-1 bispecific antibodies combine checkpoint blockade with CTLA-4 or VEGF targeting. Can one engineered molecule offer ...